Eastwood Bio EBITDA vs. Cash And Equivalents
| EBM Stock | CAD 0.54 0.11 16.92% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -358.4 K | Current Value -376.3 K | Quarterly Volatility 202.2 K |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.4 | 0.57 |
|
|
For Eastwood Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Eastwood Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Eastwood Bio Medical Canada utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Eastwood Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Eastwood Bio Medical Canada over time as well as its relative position and ranking within its peers.
Eastwood |
Eastwood Bio Medical Cash And Equivalents vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Eastwood Bio's current stock value. Our valuation model uses many indicators to compare Eastwood Bio value to that of its competitors to determine the firm's financial worth. Eastwood Bio Medical Canada is one of the top stocks in ebitda category among its peers. It also is one of the top stocks in cash and equivalents category among its peers . At this time, Eastwood Bio's EBITDA is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eastwood Bio's earnings, one of the primary drivers of an investment's value.Eastwood Cash And Equivalents vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Eastwood Bio |
| = | (398.19 K) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Eastwood Bio |
| = | 708.26 K |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Eastwood Cash And Equivalents Comparison
Eastwood Bio is currently under evaluation in cash and equivalents category among its peers.
Eastwood Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Eastwood Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Eastwood Bio will eventually generate negative long term returns. The profitability progress is the general direction of Eastwood Bio's change in net profit over the period of time. It can combine multiple indicators of Eastwood Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 8.6 K | 7.6 K | |
| Operating Income | -455.4 K | -478.2 K | |
| Net Loss | -491.9 K | -516.5 K | |
| Income Before Tax | -491.9 K | -516.5 K | |
| Total Other Income Expense Net | -36.5 K | -38.3 K | |
| Net Loss | -134.9 K | -141.6 K | |
| Net Loss | -491.9 K | -516.5 K | |
| Income Tax Expense | (1.15) | (1.21) | |
| Net Interest Income | -25.3 K | -24.1 K | |
| Change To Netincome | 5.3 K | 5.1 K | |
| Net Loss | (0.01) | (0.01) | |
| Income Quality | 0.03 | 0.03 |
Eastwood Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Eastwood Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Eastwood Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Eastwood Bio's important profitability drivers and their relationship over time.
Use Eastwood Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eastwood Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eastwood Bio will appreciate offsetting losses from the drop in the long position's value.Eastwood Bio Pair Trading
Eastwood Bio Medical Canada Pair Trading Analysis
The ability to find closely correlated positions to Eastwood Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eastwood Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eastwood Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eastwood Bio Medical Canada to buy it.
The correlation of Eastwood Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eastwood Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eastwood Bio Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eastwood Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Eastwood Bio position
In addition to having Eastwood Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Office Supplies Thematic Idea Now
Office Supplies
Companies producing and selling office supplies, and accessories. The Office Supplies theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Office Supplies Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Eastwood Stock Analysis
When running Eastwood Bio's price analysis, check to measure Eastwood Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio is operating at the current time. Most of Eastwood Bio's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio's price. Additionally, you may evaluate how the addition of Eastwood Bio to your portfolios can decrease your overall portfolio volatility.